Systemic Lupus Erythematosus

Hightower Clinical conducted studies to evaluate the effectiveness of a new study drug in improving the symptoms for patients living with Systemic Lupus Erythematosus (SLE).

Innovative Clinical Study on Systemic Lupus Erythematosus

Systemic Lupus Erythematosus, or SLE, is a chronic autoimmune disease in which the body’s immune system mistakenly attacks its own tissues. This can lead to inflammation and damage to organs such as the skin, joints, kidneys, heart, and lungs. Symptoms often include fatigue, joint pain, skin rashes, and fever, and they can vary widely from person to person.

Hightower Clinical conducted studies to evaluate a new investigational therapy for patients with SLE who had already received standard care. The trials aimed to explore whether this therapy could help improve SLE symptoms and overall quality of life, while also contributing to a better understanding of the disease and potential future treatment options.

Current Status

Not Recruiting

Study Count

Study Information